Management and Healthcare Utilization of Patients With COPD and Asthma During the COVID-19 Epidemic in Beijing
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 153
- 试验地点
- 1
- 主要终点
- Frequency of exacerbation during the COVID-19 epidemic
研究概览
简要总结
During the COVID-19 epidemic, the medical treatment, disease status, and medication status of patients with chronic airway disease have not been studied. The purpose of this study is to investigate the management and healthcare utilization of patients with chronic airway disease and the influencing factors during the COVID-19 epidemic.
详细描述
During the COVID-19 epidemic, the medical treatment, disease status, and medication status of patients with chronic airway disease have not been studied. The purpose of this study is to investigate the management and healthcare utilization of patients with chronic airway disease and the relevant factors during the COVID-19 epidemic. Using cross-sectional research methods, telephone interviews and questionnaire surveys were used to investigate the management and healthcare utilization of patients with chronic airway disease （COPD and asthma）during the COVID-19 epidemic.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 40 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •COPD patients and asthma patients in the Chronic Airway Disease Database in Peking University Third Hospital.
排除标准
- •Refusal to participate in this study; cognitive dysfunction.
结局指标
主要结局
Frequency of exacerbation during the COVID-19 epidemic
时间窗: through study completion, an average of 2 week.
Frequency of exacerbation during the COVID-19 epidemic
Respiratory symptoms
时间窗: through study completion, an average of 2 week.
COPD Assessment Test (CAT)
次要结局
未报告次要终点
研究者
Sun Yongchang
Head of Respiratory and Critical Care Medicine
Peking University Third Hospital